(Q44530977)

3 December 2017

title

Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients (English)

1 reference

3 December 2017

5

1 reference

3 December 2017

Eric Bruckert

1

1 reference

3 December 2017

Michel Lièvre

2

1 reference

3 December 2017

Philippe Giral

3

1 reference

3 December 2017

Gaetano Crepaldi

4

1 reference

3 December 2017

Matthias Vrolix

6

1 reference

3 December 2017

Eran Leitersdorf

7

1 reference

3 December 2017

Sylvie Dejager

8

1 reference

3 December 2017

publication date

1 July 2003

1 reference

The American Journal of Geriatric Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

12

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

225-231

1 reference

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Clinically relevant differences between the statins: implications for therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

Clinical pharmacokinetics of fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.02000.X

10.1111/J.1076-7460.2003.02000.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference